Skip to content

A study to evaluate the effectiveness of homoeopathic medicines in patients suffering from piles (hemorrhoids)

Effectiveness of Homoeopathic Medicines in Hemorrhoids â?? An Experimental Study - HHEMS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099571
Enrollment
70
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids Health Condition 2: K641- Second degree hemorrhoids

Interventions

Intervention1: Individualized Homoeopathic medicines: Individualized Homoeopathic medicines selected based on totality of symptoms using Synthesis 9.1 (Radar Opus repertory) and standard Materia Medic

Sponsors

DR SHREYANCE PARAKH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients attending OPD with features suggestive of hemorrhoids. 2. Confirmed diagnosed cases of hemorrhoids, taking treatment from other system of medicine, feeling no relief or recurrence & seeking homoeopathic treatment. 3. Patients between the age group of 20 â?? 60. 4. Cases of hemorrhoids with 1st and 2nd degree. 5. Patients giving consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Cases of hemorrhoids due to secondary etiology. 2. Cases of 3rd and 4th degree hemorrhoids. 3. Patients with other systemic diseases. 4. Patients with malignancies. 5. Cases with complications. 6. Patients with pregnancy leading to obstruction of the portal circulation, lactating mothers.

Design outcomes

Primary

MeasureTime frame
Change in Hemorrhoid Symptom Severity (HSS) Score before and after Homoeopathic treatment.Timepoint: At baseline (pre-treatment) and at the end of treatment (post-treatment). Follow-up assessments will be done during the treatment period as per OPD visits.

Secondary

MeasureTime frame
Improvement in associated symptoms and overall patient well-being.Timepoint: During each follow-up visit and at the end of treatment.

Countries

India

Contacts

Public ContactDr Shreyance Parakh
shaliniankushe123@gmail.com9827563296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026